DARAPRIM

LOE Approaching

pyrimethamine

NDAORALTABLETPriority Review
Approved
Jan 1953
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
7

Mechanism of Action

Dihydrofolate Reductase Inhibitors

Pharmacologic Class:

Dihydrofolate Reductase Inhibitor Antimalarial

Clinical Trials (5)

NCT03258762Phase 1Completed

Phase I Study of Pyrimethamine in Healthy Japanese and Caucasian Subjects

Started Sep 2017
14 enrolled
Toxoplasmosis
NCT01103063Phase 3Terminated

Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa

Started Oct 2010
2,891 enrolled
Intermittent Preventive Treatment In Pregnancy (IPTp)
NCT00084240Phase 2/3Terminated

Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast Asia

Started Mar 2004
32 enrolled
Malaria, Falciparum
NCT00074841Phase 2/3Completed

Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India

Started Sep 2003
230 enrolled
PLASMODIUM FALCIPARUM MALARIA
NCT00158548Phase 3Completed

ACT With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in Pakistan

Started Jun 2001
650 enrolled
MalariaFalciparum MalariaVivax Malaria